Valuation Acepodia, Inc.

Stocks

End-of-day quote Taipei Exchange 30/10/2026			5-day change	1st Jan Change
12.80 ^TWD	-4.12%		-4.12%	-16.61%

09-04	Acepodia Receives FDA Clearance for Ind Application for ACE723, A Novel Dual-Payload Antibody-Drug Conjugate	CI
08-13	Acepodia, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2023	2024	2025
Market Cap ¹	19,362	9,977	8,936
Change	-	-48.47%	-10.43%
Enterprise Value (EV) ¹	13,342	4,157	5,395
Change	-	-68.84%	29.77%
P/E	-23.7x	-20x	-11.8x
PBR	3.01x	1.58x	1.65x
PEG	0.2x	0.5x	-0.2x
Capitalization / Revenue	1,166,891,707x	23,364,805,084x	48,303,239,524x
EV / Revenue	-	-	-
EV / EBITDA	-31.5x	-5.75x	-5.97x
EV / EBIT	-30.6x	-5.49x	-5.57x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-1.441	-0.871	-1.301
Distribution rate	-	-	-
Net sales	16.59	0.427	0.185
EBITDA ¹	-423.7	-722.8	-903.4
EBIT ¹	-436	-757.9	-969.2
Net income ¹	-817.3	-496.7	-754.4
Net Debt ¹	-6,020	-5,820	-3,541
Reference price ²	34.15	17.45	15.35
Nbr of stocks (in thousands)	566,976	571,735	582,156
Announcement Date	25/03/24	19/03/25	25/03/26

¹TWD in Million²TWD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ACEPODIA, INC.	-	-	-	-	239M
WUXI APPTEC CO., LTD.	16.97x	6.42x	12.3x	1.76%	64.38B
ARGENX SE	30.03x	8.21x	26.91x	0.04%	56.16B
LONZA GROUP AG	37.32x	6.62x	19.78x	0.87%	54.16B
IQVIA HOLDINGS INC.	35.94x	3.4x	14.66x	-.--%	45.33B
BEONE MEDICINES AG	49.01x	5.65x	30.93x	-.--%	42.25B
REVOLUTION MEDICINES, INC.	-19.75x	191.25x	-21.04x	-.--%	40.78B
GENMAB A/S	46.05x	8.16x	27.33x	-.--%	33.8B
CELLTRION, INC.	31.61x	8.04x	20.91x	0.41%	32.25B
WUXI BIOLOGICS (CAYMAN) INC.	27.18x	5.72x	14.84x	-.--%	23.57B
Average	28.26x	27.05x	16.29x	0.34%	39.29B
Weighted average by Cap.	27.79x	25.71x	16.39x	0.45%